According to current guidelines, genetic testing in Germany is recommended in BC patients, who have at least a 10% prior probability of carrying a BRCA1/2 mutation based on clinical criteria as age of manifestation, family history and contralateral disease [5] and, only since end of 2016, considering receptor triple negativity before age 50. Here, BRCA1 is linked to breast cancer.